Engineering biology is already transforming technology and science, and a consortium of researchers across many disciplines in the international Genome Project-write is calling for more discussion among scientists, policy makers and the general public to shepherd future development.
In a policy forum article published in the October 18 issue of Science, the authors outline the technological advances needed to secure the transformative future of synthetic biology and express their concerns that the implementation of the relatively new discipline remains safe and responsible.
Two researchers with the University of Tennessee Institute of Agriculture are co-authors on the piece titled “Technological challenges and milestones for writing genomes: synthetic genomics requires improved technologies.” Neal Stewart and Scott Lenaghan with the UTIA departments of Plant Sciences and Food Science, respectively, join Nili Ostrov, a Ph.D. research fellow in genetics at Harvard Medical School, and 18 other leading scientists from a number of institutions and disciplines, in outlining a potential timeline for the development of what they call transformative advances to science and society.
Stewart and Lenaghan are the co-directors of the UT Center for Agricultural Synthetic Biology (CASB). Formed in 2018, Stewart says CASB is the first synthetic biology center in the world aimed specifically at improved agriculture. A professor of plant sciences in the UT Herbert College of Agriculture, Stewart also holds the endowed Racheff Chair of Excellence in Plant Molecular Genetics. Lenaghan is an assistant professor in the Department of Food Science who also holds an adjunct position in the UT Mechanical, Aerospace, and Biomedical Engineering (MABE) Department.
Synthetic biology uses computational techniques to help scientists identify genes that result in beneficial traits. In agricultural practices, these characteristics can then be triggered so that plant and animal production is improved. In addition to improved biology, Lenaghan hopes the CASB will allow for collaborations to expand the current definition of synthetic biology beyond molecular biology tools, translating advances into synthetic and engineered constructs, such as micro/nanorobots, diagnostic devices and smart materials that can benefit society beyond the food we produce and eat.
The paper’s authors assert, “A highly interdisciplinary, multinational effort from government and private sectors will help achieve and disseminate these advances to make an impact in biomedical, pharmaceutical, agricultural, and chemical industries.”
Emerging technologies and improvements to existing gene synthesis methods are identified and needed, say the paper’s authors, in four major areas to advance synthetic genomics within the next ten years: genome design, DNA synthesis, genome editing, and chromosome construction. But first they say substantial improvements are needed to reduce the cost and increase the speed and reliability of genetic tools.
“In a world that expects to sustain a population of more than 9 billion people by the year 2050, we will have to have more efficient and productive crop production to survive,” asserts Stewart. “Writing whole plant genomes, such as the relatively small one in chloroplasts, could revolutionize crop productivity simply by making photosynthesis more efficient. This roadmap paper tells us how to get there safely.”
The Latest on: Synthetic biology
via Google News
The Latest on: Synthetic biology
- New Firm OMX Ventures, Backed By Billionaire Merieux Family, Comes Out Of Stealth With $150 Million Fund for Bio-Engineeringon January 12, 2021 at 5:00 am
A new venture firm, OMX Ventures, is out of stealth with its first $150 million fund, the backing of the billionaire Merieux family, and 15 investments in bio-engineering startups.
- Vancouver synthetic biology company acquires San Diego-based AI startupon January 12, 2021 at 4:47 am
Three months after raising $65 million in equity, Vancouver, Washington-based AbSci announced Tuesday it acquired a San-Diego based Artificial Intelligence startup Denovium. AbSci engineers living ...
- The Lithuanian start-up making synthetic protein design easieron January 11, 2021 at 10:05 pm
Vilnius-based start-up Biomatter Designs has raised 500,000 euros in new funding from Practica Capital, 70V, and a number of angel investors. The funds will be used by the company to further develop ...
- AbSci acquires AI startup Denovium to boost synthetic biology platformon January 11, 2021 at 9:00 pm
AbSci has acquired Denovium, a 6-person bootstrapped startup out of San Diego that uses deep learning to analyze the function and behavior of proteins. The deal will help bolster AbSci' ...
- SKB finalizes new lease agreement with Twist Bioscience Corporation ("Twist") at recently repositioned mixed-use campus, ParkWorks Industrial Centeron January 11, 2021 at 2:12 pm
General Partner of PW Venture Portland Limited Partnership, which is the owner of ParkWorks Industry Center, is pleased to announce its ...
- Synlogic Outlines Upcoming Clinical Milestoneson January 11, 2021 at 3:30 am
PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today ...
- Alma College iGEM team examines soil cleanup at local Superfund siteon January 11, 2021 at 3:00 am
The Alma College iGEM team, competing at an international synthetic biology competition for only the second time, won a gold medal in November for a project being developed to break down the chemical ...
- Senti Bio raises $105 million for its new programmable biology platform and cancer therapieson January 6, 2021 at 4:22 am
Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences ...
- rBIO Hits Key Lab Milestone with Synthetic Production of Insulinon January 4, 2021 at 10:19 am
Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.
- Synthetic Biology for Tennessee Schools: BioBuilder Partners with Niswonger Foundation on $8.8M Federal Grant for STEM Educationon December 30, 2020 at 2:03 am
The BioBuilder Educational Foundation announced that they are to partner with the Niswonger Foundation on their award of an “Education Innovation and Research” (EIR) Grant from the U.S. Department of ...
via Bing News